Diagnostic accuracy of lung ultrasound for identification of elevated left ventricular filling pressure by Hubert, Arnaud et al.
HAL Id: hal-02049698
https://hal-univ-rennes1.archives-ouvertes.fr/hal-02049698
Submitted on 18 Dec 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Diagnostic accuracy of lung ultrasound for identification
of elevated left ventricular filling pressure
Arnaud Hubert, Nicolas Girerd, Hervé Le Breton, Elena Galli, Ichraq Latar,
Maxime Fournet, Philippe Mabo, Frédéric Schnell, Christophe Leclercq,
Erwan Donal
To cite this version:
Arnaud Hubert, Nicolas Girerd, Hervé Le Breton, Elena Galli, Ichraq Latar, et al.. Diagnostic accuracy
of lung ultrasound for identification of elevated left ventricular filling pressure. International Journal
of Cardiology, Elsevier, 2019, 281, pp.62-68. ￿10.1016/j.ijcard.2019.01.055￿. ￿hal-02049698￿
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Diagnostic accuracy of Lung Ultrasound for identification of 
elevated left ventricular filling pressure 
Arnaud Hubert, M.D.1,2,3, Nicolas Girerd, M.D., PhD.4, Hervé Le Breton, M.D., PhD. 1,2,3, Elena 
Galli, M.D., PhD. 1,2,3, Ichraq Latar 4, Maxime Fournet, M.D. 1,2,3, Philippe Mabo, M.D. 1,2,3 
Frederic Schnell M.D., PhD. 1,2,5, Christophe Leclercq, M.D., PhD. 1,2,3, Erwan Donal, M.D., 
PhD. 1,2,3 
 
1 CHU Rennes, Service de Cardiologie et Maladies Vasculaires et CIC-IT 1414, Rennes, 
35000, France 
2 Université de Rennes 1, LTSI, Rennes, 35000, France 
3 INSERM, U1099, Rennes, 35000, France 
4 INSERM, Centre d’Investigations Cliniques 1433, Université de Lorraine, CHU de Nancy, 
Institut Lorrain du Cœur et des Vaisseaux, Nancy, France and INI-CRCT (Cardiovascular and 
Renal Clinical Trialists) F-CRIN network, Nancy, France. 
5 CHU Rennes, Service de Médecine du Sport, Rennes, 35000, France 
 
Corresponding author: 
Erwan Donal, 
Service de Cardiologie et Maladies Vasculaires 
CHU de Rennes 
2 rue Henri Le Guilloux, 35000 Rennes, France. 
E-mail: erwan.donal@chu-rennes.fr 
Type: Original Research 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Abstract: (193 words) 
Aims: The current algorithm in transthoracic echocardiography (TTE) proposed in the 2016 
ASE/EACVI recommendation for the estimation of left ventricular filling pressure (LVFP) is 
quite complex and time-consuming. B-lines, in lung ultrasonography (LUS), could constitute 
an interesting tool for LVFP evaluation in clinical practice, although data regarding their 
association with invasive haemodynamics are lacking. The purpose of this study was to explore 
the diagnostic accuracy of B-lines in identifying elevated left ventricular end-diastolic pressure 
(LVEDP). 
Method and results: 81 adults with significant dyspnoea (NYHA2) were prospectively 
analyzed by LUS in four areas in each hemithorax and a complete TTE within four hours prior 
to coronary angiography. Twenty-eight patients had elevated LVEDP. Clinical variables 
yielded a C-index of 79% to identify elevated LVEDP. The number of total B-lines was higher 
in the elevated LVEDP group (1.0vs17.0, p<0.0001) and significantly increased the diagnostic 
accuracy (C-index increase=10.5%, p=0.002) and net reclassification index (NRI=145.4, 113.0-
177.9, p<0.0001) on top of clinical variables.  
Conclusion: This study demonstrates the substantial diagnostic capacity of B-lines to identify 
elevated LVEDP, which appears superior to that of classical echocardiographic strategies. This 
tool should be considered in a multi-parametric approach in patients with heart failure. 
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Introduction 
Echocardiography is currently the gold standard in the routine evaluation of left 
ventricular filling pattern in patients with dyspnoea and/or heart failure. The 2016 American 
Society of Echocardiography (ASE) and European Association of Cardiovascular Imaging 
(EACVI) guidelines for the evaluation of left ventricular diastolic function[1] reported a new 
algorithm to assess the presence and severity (grade 1 to 3) of diastolic dysfunction (DD) and 
to estimate Left Ventricular Filling Pressure (LVFP). This algorithm, based on the estimation 
of left atrial volume, E wave, velocity, e’ septal and lateral velocity by Tissue Doppler Imaging 
(TDI), and maximal tricuspid velocity is quite complex and time-consuming.  
B-lines (also called “comet-tail artefacts” or “lung comet”) are linear artefacts that are 
observed during lung ultrasonography (LUS), reflecting extravascular lung water [2]. LUS is 
simple and can be applied quickly at a patient’s bedside with the same probe that is used for 
echocardiography. The utility of B-line quantification for the diagnosis of acute pulmonary 
oedema has been demonstrated in multiple studies. B-line number shows a good correlation 
with chest radiography findings, brain natriuretic peptide levels and E/e’ ratio [3–6]. In patients 
with subclinical pulmonary congestion, the assessment of B-lines allows the diagnosis of 
subclinical pulmonary congestion and is strongly associated with clinical outcome[7–9]. With 
regard to the ASE/EACVI joint recommendations which can be difficult to apply in the 
presence of severe valvulopathy and/or atrial fibrillation, B-line quantification can be 
performed in these clinical conditions and is associated with clinical outcome regardless of 
underlying heart disease [10]. Moreover, echocardiographic algorithms are influenced by 
ageing given its strong association with diastolic function impairment; this may decrease the 
diagnostic accuracy for elevated LVFP in these patients[11]. B-lines could therefore constitute 
a valuable bedside tool for LVFP evaluation in routine clinical practice. A previous study[12] 
reported a good association of B-line count and right catheter haemodynamics although did not 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
evaluate diagnostic accuracy per se and included mostly young patients (a third of the patients 
were included after heart transplant). Data regarding the association between B-lines and left 
cardiac haemodynamics in non-transplanted elderly patients are still lacking. 
The purpose of this study was to explore the diagnostic accuracy of B-lines to identify 
elevated left ventricular end-diastolic pressure (LVEDP), as assessed by left heart 
catheterization (LHC).  
Methods 
Study sample 
 We prospectively included 93 adults (18 years old) with significant dyspnoea 
(NYHA2) who underwent a coronary angiography with left heart catheterization from May 
2016 to July 2017. Patients with mitral stenosis (because of significant differences in LVEDP 
compared to other heart disease), known pulmonary fibrosis, pneumonia, active lung cancer or 
a history of recent chest trauma were excluded. Patients who had any change in diuretic 
treatment between Transthoracic Echocardiography (TTE) and LHC were also excluded. These 
exclusion criteria were chosen among conditions that alter B-line counting[13]. Clinical and 
demographic data were obtained from the review of medical records. N-terminal Pro-Brain 
Natriuretic Peptide (NT-ProBNP) testing was performed within routine care prior to the 
angiography and recorded when available. The study protocol was approved by our local ethics 
committee (authorization number: 2014-A01331-456). 
 
Transthoracic Echocardiography 
All patients underwent a standard TTE prior to LHC using a Vivid S6, E7 or E9 
ultrasound system (General Electric Healthcare, Horten, Norway). Images were recorded on a 
remote station for off-line analysis by dedicated software (EchoPAC PC, version BT 13, 
General Electric Healthcare, Horten, Norway). Interpretation was blinded from haemodynamic 
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data. Left ventricular ejection fraction (LVEF) was measured by biplane Simpson’s method, 
and LVEF50% was considered to constitute a preserved ejection fraction [14]. Typical 
diastolic parameters were measured: peak tricuspid regurgitation velocity, right atrial pressure 
estimated by inferior vena cava diameter and collapsibility, mitral LV inflow early peak (E) 
with the deceleration time and late peak (A), isovolumic relaxation time (IVRT), septal and 
lateral diastolic early peak velocity of mitral annulus (e’) and left atrial volume index 
(LAVi)[1]. 
 
Lung Ultrasonography 
Lung ultrasonography was performed immediately before a comprehensive TTE with 
patients in supine or near-to-supine position, as previously described [2]. Four different areas 
for each hemithorax were explored during five seconds (Figure 1, panel B-1). The probe was 
placed in sagittal orientation, in the intercostal space, at an imaging depth of 10 to 14 cm. Loops 
were recorded in order to maximize the number of B-lines for each zone by adjusting the gain 
to allow for optimal visualization of the pleural line and B-lines (Figure 1, panel B-2). The 
scanning lasted less than 3 minutes. Loops were stored on a remote station to perform off-line 
analysis with the same tools as those used for TTE. For each lung ultrasound zone, the number 
of B-lines was quantified from 0 to 10. Consequently, LUS scoring ranged from 0 to 80 (8-
zones method). B-line count was used either as a continuous variable or dichotomized using 
the following cut-offs: 1) 3, which has been reported to be the best cut-off for the prediction of 
stable heart failure (HF) patient outcomes[7,15], 2) 8, which approximately corresponds to a 
score of 30 when using the 28-points method, a useful cut-off in patients at discharge from HF 
hospitalization[16], and 3) the presence of one or two bilateral positive zones (> 2 B-lines on a 
recording site) as promoted by acute LUS guidelines [13] (Figure 1, panel B-3). 
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Haemodynamic data 
 LHC was performed, within four hours after TTE, via a retrograde approach from the 
radial artery. Before coronary angiography, transducers were calibrated, with a 0-level set at 
the mid-axillary line. The LVEDP was recorded continuously (25 mm/s) with a 5 French Judkin 
R4 catheter (ICU Medical, San Clemente, CA, USA) placed at the mid-LV cavity using 
fluoroscopic screening. Waveform analysis was performed from paper tracings and was blinded 
from lung and heart ultrasonographic data. The LVEDP was calculated as the mean value of 4 
consecutive heart cycles.  
An elevated LVEDP was defined by a LVEDP > 20 mmHg[17]. In our experience, a LVEDP 
cut-off of 16 mm Hg is not strongly associated with symptoms and signs of congestion.  
 
Inter- and intra-observer variability 
 Interpretation of LUS loops was repeated in 10 random patients (>10% of the total 
population). An inter-observer reproducibility assessment was performed by 4 independent 
observers. For the intra-observer reproducibility assessment, the second reading was performed 
at least 2 months after the initial evaluation. During these repeated measurements, all observers 
were blinded to previous analysis and were unaware of patient clinical and haemodynamic data.  
 
Statistical analysis 
 Continuous data are presented as the mean  standard deviation, and categorical data 
are presented as numbers. The distributions of variables were assessed visually. Comparisons 
between both groups (LVEDP  20 mm Hg or > 20 mm Hg) were performed using an unpaired 
t-test or a Mann-Whitney test for continuous variables and a χ2 test or Fisher’s exact test for 
categorical variables, as appropriate. Correlation between parameters and LVEDP was tested 
by a Spearmen test. Receiver operating characteristic (ROC) curves were created and areas 
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under the curves (AUC) were calculated for the ability of each parameter to identify patients 
with a LVEDP > 20 mmHg. In addition, continuous net reclassification improvement (NRI) 
was performed to assess the additional value of ultrasonography parameters on top of clinical 
variables in predicting LVEDP>20 mmHg. A diagnostic accuracy increase on top of these 
clinical variables was assessed using C-index differences extracted from logistic models. 
Inter- and intra-observer variabilities of B-line counting were expressed by intra-class 
correlation coefficients. 
Tests with p-values less than 0.05 were considered to be statistically significant. 
Statistical analysis was performed using SAS (SAS institute, North Carolina, US). 
 
Results 
Patient characteristics 
Among the 81 analysed patients (Figure 1, panel A), 28 had elevated LVEDP (Table 1). 
Patients with elevated LVEDP were more likely to have diabetes, chronic obstructive 
pulmonary disease (COPD) and heart failure. There were no significant differences in the 
proportion of history of chronic kidney disease, severe heart valve diseases, atrial fibrillation 
(AF) and coronary disease.  
 
Differences in lung and heart ultrasonography variables according to LVEDP 
A marked difference was identified in B-line count according to LVEDP level (median 
B-line count 1.0 (0.0 - 4.0) in patients with LVEDP<20 vs. 17.0 (9.0 - 24.0) in patients with 
LVEDP ≥ 20 mmHg, p<0.0001, Table 2). This significant difference persisted upon 
dichotomization of B-lines (all p<0.001). The 8 B-line cut-offs yielded marginally fewer true 
positive patients than the 3 B-line cut-offs (78.6% vs. 85.7%, respectively) although with 
numerous fewer false positives (9.4% vs. 34%, respectively).  
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Overall, LV diastolic parameters were more impaired in the elevated LVEDP group 
(Table 2): E/A ratio and average mitral E/é ratio were higher (1.3 vs. 0.8, p=0.001 and 15.6 vs. 
11.6, p=0.014, respectively), and E wave deceleration time and isovolumic relaxation time were 
shorter (167 vs. 216 ms, p=0.004 and 106.3 vs. 125.0 ms, p=0.035, respectively). Of note, LAVi 
was not significantly different across groups (45.7 vs. 49.1 ml.m-2, p=0.51).  
The following parameters were significantly higher in the elevated LVEDP group: peak 
Tricuspid Regurgitation (TR) velocity (2.9±0.6 cm.s-1 vs. 2.5±0.4, p=0.002), inferior vena cava 
diameter (18.5 mm vs. 11.0, p<0.0001) and estimated systolic pulmonary artery pressure (50.0 
vs. 30.0 mmHg, p=0.0007).  
 
Correlation of lung and heart ultrasonography variables with LVEDP 
The correlation between B-line count and LVEDP was higher than that observed for all 
echocardiographic parameters (r=0.62 for B-line count vs. r<0.50 for all right- or left-sided 
echocardiographic parameters, Table 3). Among LV parameters, the highest correlation was 
observed for E/A ratio (r=0.338). Peak tricuspid regurgitation velocity, inferior vena cava 
diameter and estimated systolic pulmonary artery pressure exhibited correlations with LVEDP 
ranging from 0.40 to 0.50. 
 
Diagnostic accuracy for elevated LVEDP of lung and heart ultrasonography variables (Figure 
1-panel C) 
 None of the clinical and echocardiographic parameters significantly increased the 
diagnostic accuracy for elevated LVEDP in addition to clinical variables (namely, age, NYHA 
class, signs of pulmonary congestion, diabetes, COPD and history of heart failure) except for 
IVC diameter C-Index increase of 7.1 (0.3 to 14.0), p=0.042, Table 3 and PASP C-Index 
increase of 6.3 (0.2 to 12.5), p=0.043 . Importantly, NtProBNP was also not associated with a 
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significant increase in C-index (C-Index increase of 0.8 (-5.6 to 7.2), p=0.81). In contrast, B-
line count used either as a continuous or dichotomous variable significantly increased the 
diagnostic accuracy C-index increase of 10.5 (3.7 to 17.3), p=0.002 for total B-line count; 5.9 
(-0.1 to 11.9), p=0.053 for B-lines  3; 8.6 (2.4 to 14.8), p=0.007 for B-lines  8, Table 3. The 
diagnostic accuracy obtained with the joint use of clinical variables and B-lines was excellent 
C-index=95.5 (90 to 100). These results remained consistent in subgroup analysis in the AF 
population or decreased ejection fraction (LVEF < 30%; LVEF<40%) (table in supplementary 
materials 2). 
 Reclassification was not significantly increased when using left-sided recorded 
ultrasonography parameters. In contrast, IVC diameter, peak tricuspid regurgitation velocity 
and estimated systolic pulmonary arterial pressures as well as lung ultrasonography parameters 
significantly increased reclassification. 
 Of note, the integration of the last recommendations in the evaluation of LV pressure 
did not increase either the reclassification NRI 45.0 (-5.6 to 95.6), p=0.081 or diagnostic 
accuracy C-index increase of -0.2 (-1.6 to 1.3), p=0.82. 
 Lastly, intra- and inter-observer reproducibility was excellent, with ICCs > 0.9 for both 
measurements (graphs in supplementary materials). 
 
Discussion 
In this study, B-line count as measured by lung ultrasonography (LUS) was the variable 
most strongly correlated with invasively measured LVEDP, and significantly increased both 
diagnostic accuracy and reclassification for elevated LVEDP. Strikingly, none of the left-sided 
recorded echocardiographic parameters correlated well with LVEDP or were associated with a 
similarly important increase in diagnostic accuracy for elevated LVEDP. In contrast, peak TR 
velocity and vena cava diameter were moderately correlated with LVEDP, while IVC diameter 
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significantly increased the diagnostic accuracy for elevated LVEDP. Taken together, these 
results suggest the usefulness of LUS and IVC diameter quantification for evaluating LV filling 
pressures. 
 
Lung ultrasonography to identify elevated filling pressures 
Our study is the first to demonstrate an association between elevated LVEDP measured 
by LHC and B-line count. In a previous study, Platz et al., reported a fair association of B-line 
count with right-sided haemodynamic variables [12], whereas no significant association was 
identified with wedge pressures. In contrast, in the present study, we found a moderate 
association between B-line count and LV filling pressures. The mismatch between wedge 
pressures and pulmonary congestion observed in some patients [18] could account for these 
discrepancies. Furthermore, Halpern et al. recently questioned the relevance of wedge pressure 
to correctly classify pre- and post-capillary hypertension[19]; thereby casting some doubt on 
the ability of wedge pressure to appropriately identify pulmonary oedema. Consequently, our 
study strengthens the case of LUS for the correct assessment of heart haemodynamics that are 
relevant for congestion evaluation (i.e., LVEDP).  
A 28-zone LUS is usually used in ambulatory or hospitalized patients with heart failure 
during their hospital stay [6,10,16]. In this study, we used a simplified technique using 8 
scanning zones, similar to the imaging strategy used by Platz et al. in ambulatory patients[12]. 
However, B-line quantification using a score graded on a scale of 80 was used as opposed to 
the diagnosis algorithm used in the emergency department. The strong association and 
diagnostic accuracy of this semi-quantitative simplified technique, which can be performed in 
a few minutes, suggest its adequacy for routine clinical practice. The finding of 0.3 B-lines or 
more per scanning site does appear as a reliable threshold to identify high-risk ambulatory HF 
patients[7,15,20] (adjusted hazard ratio for death or hospitalization for HF 4.08, 1.95-8.54; 
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p<0.001). Our study provides the haemodynamic background for this observation as patients 
with 0.3 B-lines or more are very likely to have a LVEDP higher than 20 mmHg.  
On the other hand, the use of 8 B-lines as a cut-off for a 28-point technique (i.e., a 
similar 0.3 B-lines per scanning site) could provide similar diagnostic accuracy with a reduced 
risk of misclassification[15], but at the expense of a moderately longer acquisition time.  
 
 
Echocardiography to identify elevated filling pressures 
IVC diameter and peak TR velocity were found to be relevant markers of elevated 
LVEDP. Ommen et al. demonstrated a clear correlation between IVC diameter and right atrial 
pressure [21] that could be increased as a result of LV diastolic dysfunction, hypervolemia or 
both. Peak TR velocity is a marker of elevated pulmonary artery systolic pressure (PASP). 
Transthoracic echocardiography ascertains the pre- or post-capillary status of pulmonary 
hypertension [22]; however, postcapillary hypertension is the most frequent in patients with HF 
and/or LV diastolic dysfunction [23]. When associated with LUS, and based on the results of 
our study, IVC does appear to be the best candidate to identify elevated LVEDP since it was 
the only parameter to significantly increase diagnostic accuracy on top of clinical variables. 
 
Weaknesses of traditional LV echocardiographic parameters to identify LVEDP 
Typical markers of LV diastolic dysfunction that are used as individual markers did not 
effectively identify elevated LVEDP. In addition to an international study by Sato et al. [24], 
Lancellotti et al., in a recent multicentre European study [25], reported concurring results. Most 
importantly, the algorithm recommended in the 2016 ASE/EACVI recommendations yielded 
only a moderate performance for elevated LVEDP (C-index 0.78). In our study, the diagnostic 
accuracy of clinical variables (C-index 0.79) was similar to that of clinical variables and the 
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2016 ASE/EACVI algorithm (C-index 0.79), suggesting that the algorithm has no additional 
clinical relevance to better assess congestion in patients with HF. This result further adds to the 
ongoing debate regarding the usefulness of current algorithms to identify elevated LV filling 
pressures [26,27].  
The poor diagnostic capacity of the aforementioned algorithm in our cohort could be 
the consequence of the limitations of echocardiographic evaluation: high E-wave velocity can 
be observed in patients with mitral regurgitation, e’ can be altered by mitral annulus 
calcifications rather than LV filling pressures, etc. For LA volume, numerous confounding 
factors could increase atrial size including AF (approximately 30% of the study population), 
mitral insufficiency or aortic stenosis. LA volume seemingly constitutes more of a LV 
remodelling marker than a LV filling marker, except for a highly selected population. In 
contrast, LUS is not influenced by these cardiac conditions, which in turn could translate into 
better diagnostic accuracy.  
 
Clinical implications 
B-lines are an efficient marker of elevated LVFP. Consequently, they should be more 
frequently implemented in the assessment of LV diastolic function and LVFP. Their 
implementation could moreover be extremely easy in routine practice, either prior to or 
immediately after transthoracic echocardiography, and could be completed within less than 3 
minutes.  
In addition, because of the portability of recently introduced hand-held devices, LUS 
could further be easily performed throughout the course of in-hospital management or in the 
outpatient setting. We do believe, as other authors [10,28,29], that LUS is more accurate than 
lung auscultation [30,31] and should thus be routinely performed in patients with HF as an 
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extension of clinical examination. Whether this powerful diagnostic tool can help better tailor 
HF treatment and improve clinical outcomes remains to be tested in clinical trials. 
 
Limitations 
Limitations of this study include its single-centre nature and moderate sample size. 
Results herein should therefore be interpreted with caution and warrant confirmation in larger 
multicentre studies. 
LVEDP was considered to be the gold standard in our study although some authors 
consider that the mean LAP provides a better estimation of pulmonary congestion [32]. 
However, rather than including patients with AF in whom LAP usefulness is questionable, 
LVEDP was preferentially used as the outcome of our study. In addition, patients with mitral 
stenosis were excluded in order to decrease the risk of error in filling pressure estimation using 
LVEDP. 
B-lines can have non-cardiogenic origin. Although patients with a high risk of false 
positive LUS exams (pulmonary fibrosis, etc.) were excluded, we cannot rule out the possibility 
that some of the patients included in this cohort had B-lines of non-cardiac origin. However, 
despite these potential measurement caveats, LUS yielded an excellent diagnostic accuracy for 
elevated LVEDP. 
 
Conclusion 
This study demonstrates the important diagnostic capacity of B-lines in identifying elevated left 
ventricular end-diastolic pressure. This tool should be considered in a multi-parametric 
approach of patients with HF. The simplicity of LUS and IVC diameter measurement allows 
the use of a hand-held device to quickly, easily and adequately evaluate LV filling pressure. 
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Tables and Figures  
Figure 1:  
Panel A: Flow chart 
Panel B: Method of B-line quantification. 
Panel 1: The four explored areas on the right hemithorax; Panel 2: Example of a frozen loop of 
lung ultrasonography with B-lines; Panel 3: The different analysed cut-offs. A: one bilateral 
positive zone (defined by ≥ 3 B-lines in the same zone); B: two bilateral positive zones; C: 
Simplified B-line count: sum of all B-lines in the eight zones using two different cut-offs: ≥3 
or ≥8 B-lines. 
 
Panel C: ROC curves of the best indices and ASE/EACVI algorithm for the 
diagnosis of elevated LVEDP. 
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Table 1: Baseline characteristics 
LVEDP: Left Ventricular End Diastolic Pressure; BMI: Body Mass Index; MR: Mitral regurgitation; AR: Aortic Regurgitation; 
AF: Atrial Fibrillation; COPD: Chronic Obstructive Pulmonary Disease; MDRD: Creatinine clearance by the MDRD formula 
(Modification of Diet in Renal Disease); Hb: Haemoglobin; NT-ProBNP: N-terminal-Pro Brain Natriuretic Peptide; ACEi: 
Angiotensin Conversion Enzyme inhibitors; ARAII: Angiotensin Receptor II Antagonists, SBP: Systolic Blood Pressure; DBP: 
Diastolic Blood Pressure 
 
  
  Overall  
n=81 
LVEDP < 20 mmHg 
n=53 
LVEDP ≥ 20 mmHg  
n=28 
p-value 
Age (years) 75 (67 - 80) 75 (70 - 80) 75 (64 - 79) 0.49 
Sex, male 55 (67.9%) 34 (64.2%) 21 (75.0%) 0.32 
BMI (kg.m-²) 26 (23 - 30) 26 (22 - 30) 26 (23 - 30) 0.65 
Smoking 31 (38.3%) 20 (37.7%) 11 (39.3%) 0.89 
Hypertension 56 (69.1%) 37 (69.8%) 19 (67.9%) 0.86 
Dyslipidaemia 37 (45.7%) 24 (45.3%) 13 (46.4%) 0.92 
Diabetes mellitus 17 (21.0%) 6 (11.3%) 11 (39.3%) 0.003 
Heart Failure 41 (50.6%) 21 (39.6%) 20 (71.4%) 0.007 
Coronaropathy 40 (49.4%) 28 (52.8%) 12 (42.9%) 0.39 
Severe Valvulopathy 35 (43.2%) 24 (45.3%) 11 (39.2%) 0.96 
      Severe Aortic Stenosis 24 (29.6%) 17 (32.1%) 7 (25.0%)  
      MR ≥ 3/4 9 (11.1%) 5 (9.4%) 4 (14.3%)   
      AR ≥ 3/4 2 (2.5%) 2 (3.8%) 0 (0.0%)   
AF history 25 (30.9%) 18 (34.0%) 7 (25.0%) 0.41 
      paroxysmal 12 (14.8%) 8 (15.1%) 4 (14.3%) 1.0 
      permanent 13 (17.3%) 10 (20.8%) 3 (10.7%) 0.36 
COPD 6 (7.4%) 1 (1.9%) 5 (17.9%) 0.017 
Renal insufficiency 24 (29.6%) 13 (24.5%) 11 (39.3%) 0.17 
Biology         
MDRD (mL.min-1) 68.2 ± 21.3 69.6 ± 19.8 65.5 ± 24.0 0.41 
Hb (g.dL-1) 13.5 (12.2 - 14.8) 13.6 (12.4 - 14.8) 13.4 (12.2 - 14.6) 0.69 
NT-ProBNP (pg.mL-1) 
(n= 49 – 31/18) 
2013.9 ± 2448.7  1248.1 ± 1603.2  3332.7 ± 3079.6  0.014 
Medications         
B-blockers 47 (58.0%) 30 (56.6%) 17 (60.7%) 0.72 
Calcium channel blocker 4 (4.9%) 2 (3.8%) 2 (7.1%) 0.61 
ACEi/ARAII 50 (61.7%) 35 (66.0%) 15 (53.6%) 0.27 
Thiazide diuretic 2 (2.5%) 1 (1.9%) 1 (3.6%) 0.49 
Spironolactone 9 (11.1%) 7 (13.2%) 2 (7.1%) 0.49 
Physical examination         
Heart rate (bpm) 73 ± 15 71 ± 13 75 ± 19 0.34 
SBP (mmHg) 135 ± 22 137 ± 22 131 ± 22 0.25 
DBP (mmHg) 74 ± 13 74 ± 13 74 ± 14 0.91 
NYHA        0.0001 
      2 59 (72.8%) 46 (86.8%) 13 (46.4%)   
      3 – 4 22 (27.2%) 7 (13.2%) 15 (53.6%)   
Angina 18 (22.2%) 15 (28.3%) 3 (10.7%) 0.070 
Right heart failure clinical signs 13 (16.0%) 5 (9.4%) 8 (28.6%) 0.052 
Left heart failure clinical signs 10 (12.3%) 2 (3.8%) 8 (28.6%) 0.003 
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Table 2: Ultrasonographic and catheterization characteristics 
  Overall 
n=81 
LVEDP < 20 mmHg 
n=53 
LVEDP ≥ 20 mmHg 
n=28 
p-value 
AF during TTE 19 (23.5%) 12 (22.6%) 7 (25.0%) 0.81 
Total B-lines  3.0 (0.0 - 12.0) 1.0 (0.0 - 4.0) 17.0 (9.0 - 24.0) < 0.0001 
≥ 3 B-Lines 45 (51.9%) 18 (34%) 24 (85.7%) < 0.0001 
≥ 8 B-lines 27 (33.3%) 5 (9.4%) 22 (78.6%) < 0.0001 
1 positive zone in each side* 16 (19.8%) 1 (1.9%) 15 (53.6%) < 0.0001 
2 positive zones in each side* 10 (12.3%) 0 (0.0%) 10 (35.7%) < 0.0001 
LV systolic function         
Preserved LVEF 44 (54.3%) 34 (64.2%) 10 (35.7%) 0.015 
LVEF (%) 52.0 (34.0 - 61.4) 53.0 (43.0 - 62.0) 39.0 (30.0 - 55.3) 0.027 
GLS (%) -12.8 (-18.0 - -8.6) -14.7 (-18.4 - -10.0) -10.1 (-16.6 - -7.8) 0.054 
LVESVi (ml.m-2) 31.8 (19.5 - 50.6) 27.8 (18.8 - 46.0) 46.2 (29.5 - 63.3) 0.043 
LVEDVi 69.0 (50.4 - 86.7) 63.3 (47.6 - 81.0) 74.0 (59.6 - 92.8) 0.103 
Mitral S average (cm.s-1) 6.0 (4.5 - 7.5) 6.0 (5.0 - 7.5) 5.5 (4.0 - 6.0) 0.015 
LV diastolic function         
Mitral E (cm.s -1) 81 (66 - 102) 79 (63 - 94) 92 (74 - 108) 0.078 
Mitral A (cm.s-1) (n=62) 75 (56 - 104) 87 (65 - 104) 62 (34 - 78) 0.003 
E/A ratio (n=62) 0.9 (0.7 - 1.6) 0.8 (0.6 - 1.3) 1.3 (1.0 - 2.9) 0.001 
E wave, deceleration time (ms) 186.0 (148.4 - 259.0) 216.0 (164.0 - 305.0 167.0 (118.8 - 190.5 0.004 
e’ septal (cm.s-1) 5.8 ± 2.5 6.0 ± 2.3 5.5 ± 2.7 0.39 
e’ lateral (cm.s-1) 7.0 (5.0-10.0) 8.0 (5.0-10.0) 6.5 (4.5-8.5) 0.31 
Mitral e’ average (cm.s -1) 6.5 (4.5 - 8.0) 7.0 (5.0 - 8.5) 5.8 (4.3 - 7.8) 0.18 
Mitral E/e’ septal 15 (11-21) 13 (10-19) 20 (14-26) 0.017 
Mitral E/e’ lateral 11 (8-17) 10 (8-15) 13 (10-20) 0.021 
Mitral E/e’ average of annuli  12.5 (9.3 - 18.3) 11.6 (8.6 - 15.9) 15.6 (11.4 - 22.0) 0.014 
LV isovolumic relaxation time (ms) 118.0 ± 36.6 125.0 ± 35.6 106.3 ± 35.7 0.035 
LAVi (ml.m-2) 48.5 (33.4-62.3) 45.7 (33.3 - 62.3) 49.1 (36.4 - 62.6) 0.51 
RV systolic and diastolic functions         
RAVi (ml.m-2) 25.5 (19.5 - 34.7) 23.6 (18.9 - 31.2) 28.7 (20.4 - 51.1) 0.046 
RV area change (%) 42.0 ± 12.9 45.2 ± 11.4 36.0 ± 13.7 0.002 
TAPSE  22.0 (18.0 - 25.0) 23.0 (19.0 - 26.0) 20.5 (16.0 - 24.5) 0.14 
RV free wall strain (%) -21.6 ± 7.0 -22.5 ± 6.6 -20.0 ± 7.4 0.15 
RV IVA  1.4 (0.9 - 2.1) 1.3 (0.9 - 2.1) 1.4 (0.9 - 1.8) 0.94 
Peak TR velocity (m.s-1) 2.6 ± 0.5 2.5 ± 0.4 2.9 ± 0.6 0.0019 
IVC dimension (mm) 13.0 (8.5 – 17.0) 11.0 (7.0 – 15.0) 18.5 (15.0 - 20.0) <0.0001 
PASP (mmHg) 34.0 (26.0 - 45.0) 30.0 (25.5 - 36.5) 50.0 (30.0 - 60.0) 0.0007 
Catheterization         
LVEDP (mmHg) 16.0 (12.0 - 22.0) 14.0 (10.0 - 16.0) 25.0 (21.5 - 30.0) < 0.0001 
LV-PreA (mmHg) (n=62) 10.0 (6.5 - 15.5) 8.0 (5.0 - 10.0) 16.5 (13.0 - 18.0) < 0.0001 
LVESP (mmHg) 153.9 ± 33.1 155.6 ± 33.2 150.6 ± 33.4 0.53 
LVEDP: Left Ventricular End Diastolic Pressure; AF: Atrial Fibrillation; TTE: Trans-Thoracic Echocardiography; LVEF: Left 
Ventricular Ejection Fraction; GLS: Global Longitudinal Strain; LVESVi: Left Ventricular End Systolic Volume index; 
LVEDVi: Left Ventricular End Diastolic Volume index; LAVi: Left Atrial Volume index; RV: Right Ventricle; RAVi: Right 
Atrial Volume index; TAPSE: Tricuspid Annular Plane Systolic Excursion; IVA: IsoVolumic Acceleration; TR: Tricuspid 
Regurgitation; IVC: Inferior Vena Cava; PASP: Pulmonary Artery Systolic Pressure; LV-PreA: Left Ventricular pressure just 
before A-wave; LVESP: Left Ventricular End Systolic Pressure.  
*A positive zone is defined by ≥ 3 B-lines in the same zone. 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
Table 3: Correlations with LVEDP and AUC in predicting an elevated 
LVEDP  
 Spearman's 
rho 
AUC1* (CI 95%) 
∆AUC** 
(CI 95%) 
p-
value 
∆AUC 
NRI (CI 95%) 
p-value 
NRI 
NT-ProBNP (n=49) 
0.355 86.7 (74.1 to 99.4) 0.8 (-5.6 to 7.2) 0.81 85.3 (33.7 to 136.9) 0.001 
Lung ultrasonography       
Total B-Lines 
0.621 95.5 (90.0 to 100.0) 10.5 (3.7 to 17.3) 0.002 145.4 (113.0 to 177.9) <0.0001 
≥ 3 B-Lines 
0.506 90.9 (83.7 to 98.1) 5.9 (-0.1 to 11.9) 0.053 89.2 (49.5 to 128.9) <0.0001 
≥ 8 B-lines 
0.633 93.6 (86.0 to 100.0) 8.6 (2.4 to 14.8) 0.007 145.4 (113.0 to 177.9) <0.0001 
1 positive zone in each side 
0.553 91.7 (83.8 to 99.7) 6.7 (0.4 to 13.1) 0.037 117.7 (80.7 to 154.6) <0.0001 
2 positive zones in each side 
0.514 91.0 (83.0 to 99.0) 6.0 (0.3 to 11.7) 0.039 99.2 (59.9 to 138.5) <0.0001 
LV parameters       
LVEF 
-0.117 84.5 (74.8 to 94.2) -0.5 (-1.2 to 0.3) 0.22 -12.8 (-58.5 to 32.9) 0.58 
GLS 
0.000 84.1 (74.3 to 93.9) -0.1 (-0.5 to 0.3) 0.73 -8.2 (-54.3 to 37.9) 0.73 
Mitral E 
0.209 85.4 (76.1 to 94.8) 0.5 (-2.1 to 3.0) 0.72 11.1 (-32.2 to 54.3) 0.62 
E wave, deceleration time 
-0.116 85.6 (76.8 to 94.5) 0.7 (-3.2 to 4.6) 0.74 16.2 (-29.3 to 61.7) 0.49 
E/A ratio (n=62) 
0.338 85.9 (74.5 to 97.3) 2.7 (-0.5 to 5.9) 0.097 65.2 (16.5 to 113.9) 0.009 
Ea lateral 
-0.153 84.8 (75.3 to 94.4) -0.1 (-0.9 to 0.6) 0.73 39.2 (-5.7 to 84.1) 0.087 
Ea septal 
-0.147 85.1 (75.6 to 94.6) 0.1 (-1.1 to 1.4) 0.84 44.7 (1.8 to 87.7) 0.041 
Mitral Ea average 
-0.164 84.8 (75.3 to 94.4) -0.1 (-0.6 to 0.3) 0.57 -20.8 (-66.2 to 24.7) 0.37 
Mitral annular E/Ea average 
0.316 85.8 (76.5 to 95.2) 0.9 (-1.6 to 3.3) 0.48 24.1 (-21.4 to 69.6) 0.30 
LV isovolumic relaxation time 
-0.282 87.9 (78.9 to 96.9) 2.1 (-3.2 to 7.4) 0.44 53.3 (7.7 to 99.0) 0.022 
LAVi 
0.088 84.9 (75.3 to 94.5) -0.1 (-1.3 to 1.2) 0.91 -2.7 (-47.9 to 42.6) 0.91 
RV parameters       
RV fractional area change 
-0.152 84.9 (74.7 to 95.1) 0.9 (-3.1 to 5.0) 0.65 21.4 (-25.0 to 67.7) 0.37 
TAPSE 
0.010 84.8 (75.3 to 94.4) -0.1 (-0.9 to 0.6) 0.73 8.6 (-36.8 to 54.1) 0.71 
RV free wall strain 
0.012 86.9 (78.3 to 95.6) 0.1 (-0.3 to 0.6) 0.59 -15.1 (-63.9 to 33.6) 0.54 
Peak TR velocity 
0.405 89.2 (80.1 to 98.2) 4.9 (-1.1 to 10.9) 0.11 102.0 (61.8 to 142.2) <0.0001 
IVC diameter 
0.347 90.5 (82.1 to 98.8) 7.1 (0.3 to 14.0) 0.042 135.9 (100.2 to 171.6) <0.0001 
PASP 
0.397 90.6 (82.3 to 98.8) 6.3 (0.2 to 12.5) 0.043 101.4 (62.8 to 140.0) <0.0001 
2016 ASE/EACVI algorithm 
0.175 83.0 (70.9 to 95.2) -0.2 (-1.6 to 1.3) 0.82 45.0 (-5.6 to 95.6) 0.081 
*AUC1: AUC of clinical variables + parameter; **∆AUC: Difference between AUC1 and AUC of clinical variables alone 
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NRI: Net Reclassification Index; AUC: Area Under the Curve; NT Pro-BNP: N-terminal pro Brain Natriuretic Peptide; LVEF: 
Left Ventricular Ejection Fraction; GLS: Global Longitudinal Strain; LAVi: Left Atrial Volume index; RV: Right Ventricle; 
TAPSE: Tricuspid Annular Plane Systolic Excursion; IVA: IsoVolumic Acceleration; TR: Tricuspid Regurgitation; IVC: 
Inferior Vena Cava; PASP: Pulmonary Artery Systolic Pressure  
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Highlights 
Diagnostic accuracy of Lung Ultrasound for identification of 
elevated left ventricular filling pressure 
ASE/EACVI recommendation for the estimation of left ventricular filling pressure is quite 
complex and time consuming. B-lines, in lung ultrasound, could constitute an interesting tool 
for LVFP evaluation in clinical practice, but data regarding their association with invasive 
hemodynamics are lacking. The purpose of this study is to explore the diagnostic accuracy of 
B-lines to identify elevated left ventricular end-diastolic pressure (LVEDP). 
About 81 adults with significant dyspnea (NYHA2) were prospectively analyzed. Clinical 
variables had a C-index of 79% to identify elevated LVEDP. Total B-lines number was higher in 
the elevated LVEDP group (1.0vs17.0, p<0.0001) and significantly increased diagnostic 
accuracy (C-index increase=15.5%, p=0.004) and a net reclassification index (NRI=142.0, 
108.5-175.6, p<0.0001) on top of clinical variables. In contrast, the 2016 ASE/EACVI 
recommendations did not significantly increase neither the reclassification nor the diagnostic 
accuracy. There is an important diagnostic capacity of B-lines to identify elevated elevated 
filling pressure and that is probably something to consider in our clinical routine. 
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